|
WHAT'S THIS?
|
RECENT ADDITIONS
|
New information that is relevant to publication planning is constantly being added to this freely accessible central resource.
The latest additions are highlighted below, the rest can be found via the menu on the left. We welcome suggestions and contributions from our visitors so please join in and help spread the word.
|
|
|
Making information about clinical trials publicly available
Published 25 June 2009
Rosalind L Smyth, Brough professor of paediatric medicine at the Institute of Child Health, University of Liverpool and Alder Hey Children’s Hospital explains in a BMJ Editorial, how open access to information on the EudraCT database will improve transparency.
[Link to original source material]
|
|
|
German agency refuses to rule on drug’s benefits until Pfizer discloses all trial results
Published 22 June 2009
Ned Stafford reports in the BMJ, that an independent scientific institute that conducts healthcare research and evaluations mainly on behalf of Germany’s public health insurance regulator has accused the drug giant Pfizer of "concealing" research data on its depression treatment reboxetine.
[Link to original source material]
|
|
|
New group aims to detect misuse of statistics by government and media
Published 18 June 2009
Emily Pull reports in the BMJ, the news that a new group that aims to detect and highlight the misuse of statistics was launched on 18 June to help promote the public’s confidence in statistical information.
[Link to original source material]
|
|
|
Papers with industry ties: Classic confounding conflicts
Published 15 June 2009
Stephen J Evans, Professor of Pharmacoepidemiology takes issue with a previous paper in BMJ, Cancer research papers with industry ties more likely to report favourable results, published 20 May 2009.
[Link to original source material]
|
|
|
Sponsored titles raise impartiality issue
Published 9 June 2009
PMlive.com picks up on the ongoing story about sponsored Journals in Australia. Elsevier's Excerpta Medica has revealed that between 2000 and 2005 its imprint in Australia published six industry-sponsored 'journals', which critics say gave the impression that they were peer-reviewed publications.
[Link to original source material]
|
|
|
Australian research council reviews conflict of interest requirements
Published 9 June 2009
Melissa Sweet reports in the BMJ news section that Australian researchers, universities, and other research institutions are likely to face measures aimed at ensuring conflicts of interest are declared. The National Health and Medical Research Council (NHMRC) is considering recommendations that would require researchers to publicly declare conflicts of interest on university and other institutional websites.
[Link to original source material]
|
|
|
Incomplete reporting of research in academic press releases
Published 5 June 2009
An Editorial in The Lancet reflects on a paper previously published in Annals of Internal Medicine about the poor quality and incomplete reporting shown by press releases issued by medical schools in the US. It suggests a simple tool that could be adapted to assure that press releases contain the necessary details for journalists to provide more informed coverage is the CONSORT reporting guideline for abstracts, paraphrased as: how done, how many, how effective, how important, how funded. Journalists and their audiences should expect this information as a minimum standard.
[Link to original source material]
|
|
|
Elsevier tweaks custom pub rules
Published 4 June 2009
Bob Grant writes in The Scientist about how Elsevier is revising its policies and procedures for partnering with pharmaceutical companies to create custom publications in response to recent media attention over a fake journal, called the Australasian Journal of Bone and Joint Medicine (AJBJM), created by the company and paid for by Merck.
[Link to original source material]
|
|
|
Aligning Aspirations and Realising Ambitions: the challenges of the new era of engagement between experts and the pharmaceutical industry
Published 25 May 2009
In this timely and comprehensive Expert Review, Emma D’Arcy of myPHID argues that the future of interactions between industry and the medical community will be about openly aligning aspirations and ambitions. Published in the KeywordPharma Expert Reviews series, the full report is available to download free of charge, sponsored by Fishawack Communications.
[Link to original source material]
|
|
|
Cancer research papers with industry ties more likely to report favourable results
Published 20 May 2009
Janice Hopkins Tanne reflects in the BMJ on the report from researchers at the University of Michigan (Cancer 2009 May 11) that conflicts of interest are common in research papers on cancer, and papers with conflicts are more likely to report positive results.
[Link to original source material]
|
|
|
Improving reporting standards in health research publication: How the EQUATOR Network can help medical writers
Published 13 May 2009, written by Allison Hirst and Iveta Simera
The practical aspects of “how” to achieve improved reliability of medical research literature is precisely the concern of a new international initiative, the EQUATOR Network (Enhancing the QUAlity and Transparency Of health Research).
[Access full article here].
|
|
|
Reporting of sample size calculation in randomised controlled trials: review
Published 12 May 2009
The authors in this BMJ Research article conclude that sample size calculation is still inadequately reported, often erroneous, and based on assumptions that are frequently inaccurate. Such a situation raises questions about how sample size is calculated in randomised controlled trials.
[Link to original source material]
|
|
|
First CMPP Exam Window Closes – Next Opportunity in September
Published 15 April 2009
From ISMPP
[Access full article here].
|
|
|
WHAT ELSE?
|
Early each month we send out a short email newsletter featuring the latest news and articles.
Sign up here.
|
|
|
New at
NetworkPharma.tv!
GPP2: New Good Publication Practice
Ten years after the publication of the original Good Publication Practice Guidelines, GPP2 has been developed by a steering committee of International Society for Medical Publication Professionals (ISMPP) members led by Chris Graf. In this webcast Chris explains the background, purpose and future plans for this new initiative.
Watch the broadcasts free of charge.
And watch Liz Wager and Chris Graf talking informally together about the evolution of the Good Publication Practice Guidelines.
Watch the broadcasts free of charge.
|
|
|
